MMP9 and cardiomyopathy: MMP9 protein was studied at 0.2–5.2 years and levels were higher in anthracycline-induced cardiomyopathy compared to control animals in studies with longer follow-up after anthracycline administration (0.32 higher ROM per year, p = 0.04).